Author
Listed:
- Zane Jaunmuktane
(The National Hospital for Neurology and Neurosurgery)
- Simon Mead
(Medical Research Council Prion Unit
UCL Institute of Neurology
National Prion Clinic, The National Hospital for Neurology and Neurosurgery)
- Matthew Ellis
(UCL Institute of Neurology)
- Jonathan D. F. Wadsworth
(Medical Research Council Prion Unit
UCL Institute of Neurology)
- Andrew J. Nicoll
(Medical Research Council Prion Unit
UCL Institute of Neurology)
- Joanna Kenny
(Medical Research Council Prion Unit
National Prion Clinic, The National Hospital for Neurology and Neurosurgery)
- Francesca Launchbury
(UCL Institute of Neurology)
- Jacqueline Linehan
(Medical Research Council Prion Unit)
- Angela Richard-Loendt
(UCL Institute of Neurology)
- A. Sarah Walker
(MRC Clinical Trials Unit at University College London)
- Peter Rudge
(Medical Research Council Prion Unit
National Prion Clinic, The National Hospital for Neurology and Neurosurgery)
- John Collinge
(Medical Research Council Prion Unit
UCL Institute of Neurology
National Prion Clinic, The National Hospital for Neurology and Neurosurgery)
- Sebastian Brandner
(The National Hospital for Neurology and Neurosurgery
Medical Research Council Prion Unit
UCL Institute of Neurology)
Abstract
Treatment of children with human cadaver-derived growth hormone (c-hGH) contaminated with prions resulted in transmission of Creutzfeldt–Jakob disease (CJD); unexpectedly, in an autopsy study of eight such iCJD patients, the authors found amyloid-β deposition in the grey matter typical of that seen in Alzheimer's disease and amyloid-β in the blood vessel walls characteristic of cerebral amyloid angiopathy, consistent with iatrogenic transmission of amyloid-β pathology in addition to CJD and suggests that healthy c-hGH-exposed individuals may also be at risk of Alzheimer's disease and cerebral amyloid angiopathy.
Suggested Citation
Zane Jaunmuktane & Simon Mead & Matthew Ellis & Jonathan D. F. Wadsworth & Andrew J. Nicoll & Joanna Kenny & Francesca Launchbury & Jacqueline Linehan & Angela Richard-Loendt & A. Sarah Walker & Peter, 2015.
"Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy,"
Nature, Nature, vol. 525(7568), pages 247-250, September.
Handle:
RePEc:nat:nature:v:525:y:2015:i:7568:d:10.1038_nature15369
DOI: 10.1038/nature15369
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:525:y:2015:i:7568:d:10.1038_nature15369. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.